Kobe Biocluster Looks To Support Partners, Novel Tech
This article was originally published in PharmAsia News
Executive Summary
The Foundation for Biomedical Research and Innovation (FBRI) co-ordinates Kobe’s life sciences activities and heads up the Biomedical Kansai network, Japan’s largest biocluster. It is seeking international life sciences investors and partners for licensing, co-development and funding options.